BIOCE. NEW 2023 DL-,0001
BIOCE. NEW 2023 DL-,0001
Share · US09072V6002 · BIOC · A3EG0A (XNCM)
Overview Financial Indicators
No Price
n/a

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
- - - - -3,21 % -1,00 % -99,96 %

Company Profile for BIOCE. NEW 2023 DL-,0001 Share

Biocept, Inc., a molecular oncology diagnostics company, develops and commercializes proprietary circulating tumor cell and circulating cell-free tumor DNA and RNA assays utilizing a standard blood sample. Its cancer assays provide information to healthcare providers to identify oncogenic alterations that qualify a subset of cancer patients for targeted therapy at diagnosis, progression, and monitoring to identify resistance mechanisms. The company offers assays for solid tumor indications, such as breast cancer, non-small cell lung cancer (NSCLC), gastric cancer, colorectal cancer, prostate cancer, pancreaticobiliary cancer, and ovarian cancer. It also provides cerebrospinal fluid tumor cell and ctDNA and ctRNA testing services to medical oncologists, neuro-oncologists, surgical oncologists, urologists, pulmonologists, pathologists, and other physicians; clinical trial and research services to pharmaceutical companies, biopharmaceutical companies and clinical research organizations; and RT-PCR testing services for COVID-19. The company has a collaboration with CLEARED4 to develop a system for tracking and managing COVID-19 testing requirements and test results for its customers; and with Protean BioDiagnostics, Inc. to research the ability of its Target Selector molecular assay to determine EGFR status in NSCLC patients. Biocept, Inc. was incorporated in 1997 and is headquartered in San Diego, California.

Company Data

Name BIOCE. NEW 2023 DL-,0001
Company Biocept, Inc.
Symbol BIOC
Website https://biocept.com
Primary Exchange XNCM Frankfurt
WKN A3EG0A
ISIN US09072V6002
Asset Class Share
Sector Healthcare
Industry Medical - Diagnostics & Research
CEO Mr. Darrell Taylor Esq.
Country United States of America
Currency EUR
Employees 0,1 T
Address 9955 Mesa Rim Road, 92121 San Diego
IPO Date 2014-02-05

Ticker Symbols

Name Symbol
NASDAQ BIOC

More Shares

Investors who BIOCE. NEW 2023 DL-,0001 hold also have the following shares in their portfolio:
DXC TECHNOLOGIESLOGY 18/25
DXC TECHNOLOGIESLOGY 18/25 Bond
EXPORT DEV.CANADA17/21MTN
EXPORT DEV.CANADA17/21MTN Bond
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025